Presence of high-molecular-weight forms and domain alterations of fibronectin in pleural effusion of patients with lung cancer

Clinical Biochemistry

Volumn 42, Issue 7-8, 2009, Pages 654-661

  Pupek, Małgorzata ^a   Krzyzanowska Gołab, Dorota ^a   Dyła, Tomasz ^a   Lemańska Perek, Anna ^a   Jankowska, Renata ^a   Katnik Prastowska, Iwona ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Fibronectin; Fibronectin domains; Lung inflammation; Macromolecular fibronectin; Small cell and non small cell lung cancer

Indexed keywords

EPITOPE; FIBRONECTIN; MONOCLONAL ANTIBODY;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PLASMA; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN;

ADULT; AGED; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBRONECTINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PLEURAL EFFUSION;

EID: 63649106414     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.12.018     Document Type: Article

References (34)

1. Cukierman E., Pankov R., and Yamada K.M. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 14 (2002) 633-639
2. Vogel V., Thomas W.E., Craig D.W., Krammer A., and Baneyx G. Structural insight into the mechanical regulation of molecular recognition sites. Trends Biotechnol 19 (2001) 416-423
3. Stupack D.G., and Cheresh D.A. Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene 22 (2003) 9022-9029
4. Magnusson M.K., and Mosher D.F. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 18 (1998) 1363-1370
5. Kaspar M., Zardi L., and Neri D. Fibronectin as target for tumor therapy. Int J Cancer 118 (2006) 1331-1339
6. Rintoul R.C., and Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin Sci 102 (2002) 417-424
7. Buttery R.C., Rintoul R.C., and Stehi T. Small cell lung cancer: the importance of the extracellular matrix. Int J Biochem Cell Biol 36 (2004) 1154-1160
8. Geiger B., Bershadsky A., Pankov R., and Yamada K.M. Transmembrane extracellular matrix-cytoskeleton crosstalk. Nat Rev Mo Cell Biol 2 (2001) 793-805
9. Mao Y., and Schwarzbauer J.E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24 (2005) 389-399
10. Sottile J., and Chandler J. Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol Biol Cell 16 (2005) 757-768
11. Wierzbicka-Patynowski I., and Schwarzbauer J.E. The ins and outs of fibronectin matrix assembly. J Cell Sci 116 (2003) 3269-3276
12. Pankov R., and Yamada K.M. Fibronectin at a glance. J Cell Sci 115 (2002) 3861-3863
13. Yamada K.M. Fibronectin peptides in cell migration and wound repair. J Clin Invest 105 (2000) 1507-1509
14. Kijima T., Maulik G., Ma P.C., Madhiwala P., Schaefer E., and Salgia R. Fibronectin enhances viability and alters cytoskeletal functions (with effects on the phosphatidylinositol 3-kinase pathway) in small cell lung cancer. J Cell Mol Med 7 (2003) 157-164
15. Han S., Sidell N., and Roman J. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett 219 (2005) 71-81
16. Hirnle L., and Ka{ogonek}tnik-Prastowska I. Amniotic fibronectin fragmentation and domain and sialyl- and fucosyl-glycotope expression associated with pregnancy complicated by intrauterine infection. Clin Chem Lab Med 45 (2007) 208-214
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
18. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76 (1979) 4350-4354
19. Ka{ogonek}tnik I., and Jadach J. Immunoaffinity purification of human haptoglobin using monoclonal antibodies. Arch Immunol Ther Exp 41 (1993) 303-308
20. Hooper D.C., and Peacock A.C. Determination of the subunit composition of haptoglobin 2-1 polymers using quantitative densitometry of polyacrylamide gels. J Biol Chem 251 (1976) 5845-5851
21. Hynes R.O. The dynamic dialogue between cells and matrices: Implications of fibronectin's elasticity. Proc Natl Acad Sci USA 96 (1999) 2588-2590
22. Moretti F.A., Chauhan A.K., Iaconcig A., Porro F., Baralle F.E., and Muro A.F. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem 282 (2007) 28057-28062
23. Sottile J., and Hocking D.C. Composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 13 (2002) 3546-3559
24. Yi M., Sakai T., Fassler R., and Ruoslahti E. Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity. Proc Natl Acad Sci USA 100 (2003) 11435-11438
25. Cremades M.J., Menéndez R., Rubio V., and Sanchis J. Fibronectin in bronchoalveolar lavage fluid in lung cancer: tumor or inflammatory marker?. Respiration 65 (1998) 178-182
26. Ito H., Rucker E., Steplewski A., et al. Guilty by association: some collagen II mutants alter the formation of ECM as a result of atypical interaction with fibronectin. J Mol Biol 352 (2005) 382-395
27. Przybysz M., Borysewicz K., Szechiński J., and Ka{ogonek}tnik-Prastowska I. Synovial fibronectin fragmentation and domain expressions in relation to rheumatoid arthritis progression. Rheumatology 46 (2007) 1071-1076
28. Hatton M.W., Southward S.M., Legault K.J., et al. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: effluxing fibrin(ogen) fragments contain antiangiogenic activity. J Lab Clin Med 143 (2004) 241-254
29. Toyoshima K., Kimura S., Cheng J., Oda Y., Mori K.J., and Saku T. High-molecular-weight fibronectin synthesized by adenoid cystic carcinoma cells of salivary gland origin. Jpn J Cancer Res 90 (1999) 308-319
30. Yi M., and Ruoslahti E. A fibronectin fragment inhibits tumor growth angiogenesis, and metastasis. Proc Natl Acad Sci USA 98 (2001) 620-624
31. Longtin R. Birthday of a breakthrough: Fibronectin research proves important, but not as originally expected. J Natl Cancer Inst. 96 (2004) 6-8
32. Makogonenko E., Ingham K.C., and Medved L. Interaction of the fibronectin COOH-terminal fib-2 regions with fibrin: further characterization and localization of the fib-2 binding sites. Biochemistry 8 (2007) 5418-5426
33. Pasqualini R., Bourdoulous S., Koivunen E., Woods Jr. V.L., and Ruoslahti E. A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat Med 2 (1996) 1197-1203
34. + T lymphocytes. J Immunol 164 (2000) 3236-3245